Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk ...

    www.aol.com/why-roche-stock-just-popped...

    But good news for Roche is bad news for the companies that now seem to have the weight-loss drug market to themselves. Shares of Eli Lilly (NYSE: LLY) were down 2.8% today, and Novo Nordisk (NYSE ...

  3. Weight Loss Drug Stocks Just Took a Hit. Should You Buy the ...

    www.aol.com/finance/weight-loss-drug-stocks-just...

    But for today, Roche's stock looks like it's worth purchasing on the basis of this data because the company might have a stellar product in hand. Roche and the others are all worth considering.

  4. Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the ...

    www.aol.com/look-eli-lilly-novo-nordisk...

    Shares of Lilly and Novo Nordisk fell on the news, while Roche's shares jumped nearly 6%. Could Roche be the obesity drug stock to really watch? ... Its forward price-to-earnings ratio of 15.6 is ...

  5. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    Roche. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.

  6. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a meeting in 1976, the two decided to start a biotechnology company, Genentech. Although the two confidently assert that it was the first biotech company, others clearly came before, including Cetus Corporation which was founded in 1971.

  7. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...

  8. This Big Pharma Could Become a Leading Weight-Loss Stock ...

    www.aol.com/big-pharma-could-become-leading...

    At stake will be the weight-loss drugs market, which could become as large as $100 billion or more by the end of the decade. Roche's trailing-12-month revenue is $67.7 billion. While it won't be ...

  9. Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche - AOL

    www.aol.com/better-dark-horse-weight-loss...

    Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche. Alex Carchidi, The Motley Fool. July 22, 2024 at 5:59 AM. Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's ...